Financial Performance - Revenue for the first half of 2024 was RMB 666.69 million, a decrease of 13.16% compared to the same period last year[12] - Net profit attributable to shareholders of the listed company was RMB 11.10 million, compared to a loss of RMB 37.81 million in the same period last year[12] - Net cash flow from operating activities was negative RMB 190.40 million, compared to negative RMB 12.59 million in the same period last year[12] - Basic earnings per share for the reporting period were RMB 0.0169, compared to a loss of RMB 0.0575 in the same period last year[13] - Weighted average return on equity (ROE) for the reporting period was 0.44%, an increase of 1.94 percentage points compared to the same period last year[13] - Revenue for the first half of 2024 was RMB 666.69 million, a decrease of 13.16% year-over-year[22] - Net profit attributable to shareholders was RMB 11.10 million, achieving a turnaround from a loss in the same period last year[22] - Operating costs decreased by 29.78% year-over-year, primarily due to the discontinuation of pharmaceutical sales[25] - Sales expenses increased by 24.54% year-over-year, driven by higher advertising and labor costs[25] - R&D expenses increased by 45.70% year-over-year, reflecting increased investment in R&D projects[25] - Total revenue for the first half of 2024 decreased to RMB 666,685,557.53 from RMB 767,728,571.86 in the same period last year[70] - Operating profit for the first half of 2024 improved to RMB 10,718,080.24 compared to a loss of RMB 34,721,908.83 in the first half of 2023[70] - Net profit for the first half of 2024 was RMB 14,965,972.30, a significant improvement from a loss of RMB 32,901,861.00 in the same period last year[70] - Research and development expenses increased to RMB 10,908,049.77 in the first half of 2024 from RMB 7,486,731.16 in the first half of 2023[70] - Net profit attributable to parent company shareholders was RMB 11,097,993.44, a significant improvement from a loss of RMB -37,814,688.43 in the previous period[71] - Total revenue for the first half of 2024 was RMB 377,172,686.95, an increase from RMB 313,497,815.28 in the same period last year[72] - Operating costs decreased to RMB 302,310,326.77 from RMB 311,063,090.28, reflecting improved cost management[72] - R&D expenses increased significantly to RMB 7,308,358.14, up from RMB 1,912,375.42, indicating higher investment in innovation[72] - Net cash flow from operating activities was RMB 699,264,552.10, a decrease from RMB 886,975,523.59 in the previous year[74] - Basic earnings per share improved to RMB 0.0169, compared to a loss of RMB -0.0575 in the prior period[71] - Total comprehensive income for the period was RMB 11,936,832.48, a recovery from a loss of RMB -36,832,632.04[71] - Sales revenue from goods and services provided was RMB 661,310,389.58, down from RMB 873,464,479.38 in the previous year[74] - Other income increased to RMB 2,314,720.50, up from RMB 1,896,405.03, reflecting diversified revenue streams[72] - Interest income was RMB 1,658,601.47, a decrease from RMB 3,816,322.06, indicating lower returns on financial assets[72] - Operating cash flow for the first half of 2024 was -190.4 million yuan, a significant decrease compared to -12.6 million yuan in the same period last year[76] - Cash outflow for purchasing goods and accepting services was 437.8 million yuan, down 17% from 527.3 million yuan in the previous year[76] - Cash paid for employee compensation was 166.6 million yuan, a slight decrease from 171.3 million yuan in the same period last year[76] - Cash outflow for taxes and fees increased by 33% to 201.6 million yuan compared to 151.7 million yuan in the previous year[76] - Net cash flow from investment activities was 8.5 million yuan, a significant improvement from -38.6 million yuan in the same period last year[76] - Cash received from disposal of fixed assets and intangible assets was 42.5 million yuan, a substantial increase from 27,000 yuan in the previous year[76] - Net cash flow from financing activities was 35.9 million yuan, compared to -5.8 million yuan in the same period last year[77] - Cash and cash equivalents at the end of the period decreased by 146 million yuan to 323.1 million yuan[77] - Parent company's operating cash flow was -126.2 million yuan, a significant decrease from -28.1 million yuan in the same period last year[78] - Comprehensive income for the period was 111 million yuan, contributing to an increase in undistributed profits[80] Assets and Liabilities - Total assets at the end of the reporting period were RMB 3.33 billion, a decrease of 4.35% compared to the end of the previous year[12] - Cash and cash equivalents decreased by 29.66% to 356.83 million yuan, accounting for 10.73% of total assets[28] - Accounts receivable decreased by 36.11% to 94.16 million yuan, accounting for 2.83% of total assets[28] - Prepayments decreased by 72.43% to 8.74 million yuan, accounting for 0.26% of total assets[28] - Other current assets increased by 134.00% to 10.68 million yuan, accounting for 0.32% of total assets[28] - Construction in progress increased by 69.83% to 97.66 million yuan, accounting for 2.94% of total assets[28] - Total assets decreased from 3,476,257,231.71 to 3,325,112,636.04, a decline of 4.35%[66] - Current assets decreased from 2,188,609,819.85 to 2,015,640,873.01, a decline of 7.90%[65] - Non-current assets increased from 1,287,647,411.86 to 1,309,471,763.03, a growth of 1.69%[65] - Total liabilities decreased from 945,036,906.27 to 783,123,531.45, a decline of 17.13%[66] - Current liabilities decreased from 783,694,824.50 to 624,576,634.42, a decline of 20.31%[66] - Non-current liabilities decreased from 161,342,081.77 to 158,546,897.03, a decline of 1.73%[66] - Owner's equity increased from 2,531,220,325.44 to 2,541,989,104.59, a growth of 0.43%[66] - Cash and cash equivalents decreased from 507,310,869.72 to 356,826,411.57, a decline of 29.66%[64] - Accounts receivable decreased from 147,373,377.75 to 94,158,581.41, a decline of 36.11%[64] - Inventory increased from 1,467,431,309.01 to 1,512,953,722.43, a growth of 3.10%[65] - Total assets as of June 30, 2024, were RMB 3,191,871,697.86, slightly increased from RMB 3,187,107,529.23 at the end of 2023[67] - Total liabilities as of June 30, 2024, increased to RMB 1,532,149,632.06 from RMB 1,456,254,888.83 at the end of 2023[68] - Accounts receivable decreased to RMB 8,904,540.24 as of June 30, 2024, from RMB 42,481,085.77 at the end of 2023[67] - Inventory increased to RMB 1,419,380,899.46 as of June 30, 2024, from RMB 1,364,884,114.37 at the end of 2023[67] - Total equity decreased to RMB 1,659,722,065.80 as of June 30, 2024, from RMB 1,730,852,640.40 at the end of 2023[68] - Total owner's equity at the end of the period is RMB 2,531,220,325.44, with a decrease of RMB 23,536,537.17 compared to the previous period[85] - Comprehensive income for the period shows a loss of RMB 22,069,577.53, contributing to the overall decrease in owner's equity[83] - Special reserves decreased by RMB 3,827,592.52 during the period, with RMB 3,827,592.52 used[85] - The company's total capital at the end of the period is RMB 657,796,824.00, with capital reserves of RMB 1,174,961,782.84[82] - Other comprehensive income remains unchanged at RMB 83,137,500.00[82] - Undistributed profits decreased by RMB 22,069,577.53, reflecting the impact of the period's losses[83] - Minority shareholders' equity increased by RMB 2,360,632.88, partially offsetting the overall decrease in owner's equity[83] - The company's total assets at the end of the period are RMB 2,541,989,104.59, with a slight decrease from the previous period[82] - Special reserves at the beginning of the period were RMB 23,872,596.77, which decreased to RMB 20,045,004.25 by the end of the period[83] - The company's general risk provision remains unchanged at RMB 122,917,310.76[82] - Total owner's equity at the end of the period is 1,659,722,065.80[87] - The company's comprehensive income for the period decreased by 121,810,015.90[89] - Special reserves decreased by 3,420,151.83 during the period[89] - The company's total owner's equity at the beginning of the period was 1,855,332,808.13[88] - The company's total owner's equity at the end of the period is 1,730,102,640.40[90] - The company's capital reserve is 1,174,897,068.31[87] - The company's undistributed profit is -319,365,237.72[90] - The company's total owner's equity decreased by 125,230,167.73 during the period[89] - The company's special reserves at the beginning of the period were 14,889,326.88[88] - The company's special reserves at the end of the period are 11,469,175.05[90] Environmental and Sustainability - Wastewater discharge: Chemical Oxygen Demand (COD) concentration at 30,000 mg/L, total discharge of 73.5494 tons, within the permitted limit of 3,000 tons[39] - Total nitrogen discharge concentration at 1,000 mg/L, total discharge of 2.4408 tons, within the permitted limit of 1,000 tons[39] - Ammonia nitrogen discharge concentration at 550 mg/L, total discharge of 3.5972 tons, within the permitted limit of 550 tons[39] - Total phosphorus discharge concentration at 300 mg/L, total discharge of 0.4395 tons, within the permitted limit of 300 tons[40] - Environmental protection engineering covers 5,000 square meters, established in 1996, with significant reduction in wastewater treatment[41] - Company awarded the 2023 Anhui Province Environmental Protection "Integrity Enterprise" title[46] - Carbon peak target established as a core task for future development, with differentiated emission reduction measures[46] - Promotion of electric forklifts to replace diesel forklifts, reducing fuel consumption and greenhouse gas emissions[47] - Installation of photovoltaic power generation facilities on company rooftops to increase renewable energy usage[47] Corporate Governance and Shareholding - Vice President Chen Xingjie retired due to reaching the legal retirement age[37] - No profit distribution or capital reserve conversion plan for the first half of the year[38] - The company plans to transfer 92% equity of Jintaiyang Pharmaceutical through public listing, approved by the board and shareholders[32] - The total number of ordinary shareholders at the end of the reporting period is 104,114[58] - Anhui Jinzhongzi Group Co., Ltd. holds 178,257,084 shares, accounting for 27.10% of the total shares[58] - China Bank Limited - China Merchants CSI Liquor Index Graded Securities Investment Fund holds 32,521,543 shares, accounting for 4.94% of the total shares[58] - Hong Kong Securities Clearing Company Limited holds 9,265,983 shares, accounting for 1.41% of the total shares[58] - China Construction Bank Limited - Penghua CSI Liquor Trading Open-end Index Securities Investment Fund holds 7,187,648 shares, accounting for 1.09% of the total shares[58] - Zhou Jianzhong holds 5,312,415 shares, accounting for 0.81% of the total shares[58] - Lin Wenlong holds 3,625,448 shares, accounting for 0.55% of the total shares[58] - Li Weijing holds 3,624,200 shares, accounting for 0.55% of the total shares[58] - China Merchants Bank Limited - Yinhua Fuli Selected Hybrid Securities Investment Fund holds 3,411,919 shares, accounting for 0.52% of the total shares[58] - Qiu Yunjing holds 1,978,600 shares, accounting for 0.30% of the total shares[58] Product and Market Strategy - National large-scale liquor enterprises produced 2.147 million kiloliters of liquor in the first half of 2024, a year-on-year increase of 3.0%[15] - The company's main products include Jinzhongzi series, Seed series, Zuisanqiu series, and Yingzhou series, with Jinzhongzi Fuxiang as the core product[15] - Jinzhongzi Fuxiang liquor contains 2,224 aroma substances, with key flavor components including pyrazines, esters, aldehydes, and guaiacol compounds[17] - The company's ancient fermentation pits, dating back to 1507, are among the oldest and best-preserved in the Huanghuai region, contributing to the unique microbial ecosystem[18] - The company operates 8 liquor research platforms, including a CNAS-accredited laboratory and a postdoctoral workstation, with 5 national-level liquor judges and 129 core technical personnel[19] - Jinzhongzi and Zuisanqiu are recognized as China Well-known Trademarks, and Yingzhou is designated as a China Time-honored Brand[20] - The company has established a market-oriented organizational system and performance management system through strategic restructuring with China Resources[21] - The company achieved an 80% terminal coverage rate for its core products[23] - The company launched a series of high-end activities, including the Fuxiang Baijiu Value Forum and the Fuyang Marathon, to enhance brand value[23] - The company optimized its sales management and focused on core business actions, such as the TOP store campaign and the Spring Festival campaign[23] - The company strengthened its digital infrastructure, improving overall operational efficiency and implementing projects like the five-code production line transformation[23] - The company collaborated with Jiangnan University to research and improve the brewing process and quality of Fuxiang Baijiu[23] Subsidiaries and Investments - Anhui Jintaiyang Biochemical Pharmaceutical Co., Ltd. achieved a net profit of 10.48 million yuan with total assets of 200.42 million yuan[33] - Fuyang Jinzhizi Liquor Sales Co., Ltd. achieved a net profit of 62.18 million yuan with total assets of 821.58 million yuan[33] - The company's subsidiary, Jintaiyang Pharmaceutical, enjoys a preferential corporate income tax rate of 15% from January 1, 2022, to December 31, 2024, due to its high-tech enterprise certification[177] Financial Instruments and Accounting Policies - The company's financial statements are prepared on a going concern basis, with no issues identified that would affect its ability to continue operations for the next 12 months[95] - The company's accounting period runs from January 1 to December 31[98] - The company's normal operating cycle is one year[99] - The company's functional currency is the Chinese Yuan (RMB)[100] - Significant non-wholly owned subsidiaries are those with total assets, operating income, or total profit exceeding 5% of the consolidated financial statements[101] - Important prepayments with an age exceeding 1 year and significant in amount are those exceeding RMB 5 million or 0.5% of total profit[101] - Significant construction in progress is defined as projects exceeding RMB 5 million or 0.5% of total profit[101] - Important accounts payable with an age exceeding 1 year are those exceeding RMB 5 million or 0.5% of total profit[101] - Significant contract liabilities with an age exceeding 1 year are those exceeding RMB 5 million or 0.5% of total profit[101] - Significant other payables with an age exceeding 1 year are those exceeding RMB 5 million or 0.5% of total profit[101] - The company's consolidated cash flow statement includes the cash flows of subsidiaries from the acquisition date to the end of the reporting period[106] - Disposal of subsidiaries or businesses does not adjust the opening balance of the consolidated balance sheet, but includes their income, expenses, and profits from the beginning to the disposal date in the consolidated income statement[106] - The company's long-term equity investments in

证券代码：600199 证券简称：金种子酒 公告编号：临 2024-032 安徽金种子酒业股份有限公司 关于召开2024年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带 责任。 重要内容提示： 会议召开时间：2024 年 9 月 20 日（星期五）下午 15:00-16:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网址： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2024 年 9 月 11 日（星期三）至 9 月 19 日（星期四）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 jnsy199@163.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行 回答。 安徽金种子酒业股份有限公司（以下简称"公司"）已于 2024 年 8 月 28 日 发布公司《2024 年半年度报告》，为便于广大投资者更全面深入地了解公司 2024 年半年度经营成果、财务状况，公 ...

证券代码：600199 证券简称：金种子酒 公告编号：临 2024-030 安徽金种子酒业股份有限公司 2024年半年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带 责任。 根据《上海证券交易所上市公司自律监管指引第 3 号——行业信息披露》 之《第十二号——酒制造》第十六条相关规定，现将安徽金种子酒业股份有 限公司 2024 年 1-6 月份主要经营数据（未经审计）公告如下： 单位：万元 币种：人民币 | 分产品 | 本期营业收入 | 主要代表品牌 | | --- | --- | --- | | 高端酒 | 3,704.01 | 馥合香 16、馥合香 20 系列 | | 中端酒 | 14,119.04 | 馥合香 7、馥合香 9、柔和大师系列 | | 低端酒 | 37,381.06 | 祥和系列、颍州佳酿、头号种子系列 | | 小计 | 55,204.11 | | 注：白酒产品按照厂家名义零售价为基础，细分为下列三档次，高端 （X>500 元/瓶）、中端（100＜X≤500 元/瓶）、低端（X≤100 元 ...

扣除累计已使用募集资金后，募集资金余额为 19,150.54 万元，募集资金 专用账户利息收入净额为 5,358.64 万元，募集资金专户 2024 年 6 月 30 日余 额合计为 24,509.18 万元。 二、募集资金管理情况 安徽金种子酒业股份有限公司 关于 2024 年半年度募集资金存放与实际使用情况 的 专项报告 根据中国证券监督管理委员会《上市公司监管指引第 2 号——上市公司募 集资金管理和使用的监管要求》及《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等有关规定，将安徽金种子酒业股份有限公司（以下简称 "金种子酒"或"公司"）2024 年半年度募集资金存放与实际使用情况报告如 下： 一、募集资金基本情况 经中国证券监督管理委员会证监许可[2018]1633 号文《关于核准安徽金种 子酒业股份有限公司非公开发行股票的批复》核准，公司向新华基金管理股份 有限公司、付小铜、陕西柳林酒业有限公司等 3 名特定投资者非公开发行人民 币普通股（A 股）10,202.18 万股，每股发行价格人民币 5.65 元，募集资金总 额为人民币 57,642.33 万元，根据有关规定扣除发行费用人民币 ...

证券代码：600199 证券简称：金种子酒 公告编号：临 2024-028 安徽金种子酒业股份有限公司 第七届董事会第十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及 连带责任。 重要内容提示： 一、会议召开情况 1、安徽金种子酒业股份有限公司（以下简称"公司"）第七届董事会第 十一次会议通知于 2024 年 8 月 16 日以短信及电子邮件方式发出，会议如期 于 2024 年 8 月 26 日上午 10:00 在公司总部九楼会议室召开，采取现场与线 上相结合的方式进行表决。 2、本次会议应出席董事 9 人，实际出席董事 9 人。 1、审议通过《公司 2024 年半年度报告及摘要》 本议案已经公司董事会审计委员会事前审议通过，并同意提交公司董事 ◆ 无董事对本次董事会议案投反对或弃权票。 ◆ 本次董事会议案全部获得通过。 会审议。 具体内容详见上海证券交易所网站（http://www.sse.com.cn）上的《安 徽金种子酒业股份有限公司 2024 年半年度报告》与《安徽金种子酒业股份有 限公司 2024 年半 ...

证券代码：600199 证券简称：金种子酒 公告编号：临 2024-029 第七届监事会第八次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带责任。 一、会议召开情况 1、安徽金种子酒业股份有限公司（以下简称"公司"）第七届监事会第 八次会议通知于 2024 年 8 月 16 日以短信及电子邮件方式发出，会议于 2024 年 8 月 26 日上午在公司总部九楼会议室召开，采取现场与线上相结合的方 式进行表决。 2、本次会议应出席监事 5 名，实际出席监事 5 名。 3、会议由监事会主席陈新华先生主持，本次会议的召集、召开符合《公 司法》和《公司章程》的有关规定，会议审议并通过如下议案： 二、会议审议情况 经与会监事认真审议并表决，以投票表决的方式通过了以下议案，并发 表如下意见： 安徽金种子酒业股份有限公司 1、公司 2024 年半年度报告的编制和审议程序符合法律、法规、公司章 程和公司内部管理制度的各项规定； 2、公司 2024 年半年度报告的内容和格式符合中国证监会和证券交易所 的各项规定，所包含的信息能从各 ...

证券代码：600199 证券简称：金种子酒 公告编号：临 2024-031 安安安安安安安安安安安安安 安安安安安安安安安安安安安安安安安安安安 一、战略委员会（9 人） 主任委员：谢金明 委员：赵伟、魏强、何秀侠、杨红文、金彪、薛军、吕本富、樊勇 二、审计委员会（5 人） 主任委员：樊勇 委员：谢金明、赵伟、吕本富、薛军 三、薪酬与考核委员会（5 人） 主任委员：薛军 委员：谢金明、魏强、吕本富、樊勇 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带 责任。 2024 年 8 月 26 日，安徽金种子酒业股份有限公司（下称"公司"）在公 司总部九楼会议室（以现场与通讯相结合的方式）召开第七届董事会第十一 次会议，审议通过了《关于调整第七届董事会专门委员会成员的议案》。根据 公司第七届董事会董事变化情况，为充分发挥董事会各专门委员会的专业职 能，进一步完善公司治理结构，公司结合目前实际情况，对第七届董事会各专 门委员会成员进行了调整，具体调整情况如下： 事谢金明、何秀侠、独立董事樊勇、薛军；以上各专门委员会组成公司第七届 董事会 ...

天津师事务所 法律意见书 安徽天禾律师事务所 关于安徽金种子酒业股份有限公司 根据《中华人民共和国公司法》(下称《公司法》)、《中华人民共和国证券法》(下 称《证券法》)、中国证券监督管理委员会(下称"中国证监会")《上市公司股东大会 规则》(下称《股东大会规则》以及《安徽金种子酒业股份有限公司公司章程》(下称 《公司章程》)等有关规定,安徽天禾律师事务所接受安徽金种子酒业股份有限公司 (以下简称"公司")委托,指派毛文斌、朱华耀律师(下称"天禾律师")出席公 司 2024年第一次临时股东大会(下称"本次股东大会"),对本次股东大会相关事项 进行见证,并出具法律意见。 本法律意见书是天禾律师根据对有关本次股东大会事实的了解及对我国现行法律、 法规和规范性文件的理解而做出的。 天禾律师同意将本法律意见书作为本次股东大会的必备文件予以公告并依法对所 出具的法律意见书承担责任。 天禾律师根据有关法律、法规的要求,按照律师行业公认的业务标准、道德规范 和勤勉尽责的精神,对本次股东大会的召集和召开程序、出席会议人员的资格、表决 程序及其他相关法律问题发表法律意见如下: 一、本次股东大会的召集与召开程序 E乐弹 Jn 事 ...

证券代码：600199 证券简称：金种子酒 公告编号：2024-026 安徽金种子酒业股份有限公司 2024 年第一次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 记名式投票表决方式结合网络投票方式举行。会议的召集、召开及表决方式符合 《公司法》等相关法律、法规和《公司章程》的相关规定。 (五) 公司董事、监事和董事会秘书的出席情况 (一) 股东大会召开的时间：2024 年 7 月 30 日 (二) 股东大会召开的地点：安徽省阜阳市清河东路 523 号金种子研发大楼 9 楼会议室 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 二、 议案审议情况 (一) 非累积投票议案 1、 议案名称：《关于更换公司董事的议案》 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 921 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 183,476,486 | | 3、出席会议的股东所持有表决权股 ...

安徽金种子酒业股份有限公司 2024 年第一次临时股东大会 会议资料 2024 年 7 月 30 日 2024 年第一次临时股东大会会议资料 目 录 一、程序文件 | 2024 | 年第一次临时股东大会会议议程 1 | | --- | --- | | 2024 | 年第一次临时股东大会会议须知 3 | | 二、会议议案 | | | 议案一、关于更换公司董事的议案 5 | | 2024 年第一次临时股东大会会议资料 安徽金种子酒业股份有限公司 2024年第一次临时股东大会会议议程 表决方式：现场投票与网络投票相结合的方式 一、大会介绍 1、主持人宣布现场会议开始 董事长谢金明先生介绍出席会议的公司董事、监事、高级管理人员、见证律师 等有关人员 2、董事、总经理何秀侠女士向大会报告出席现场会议的股东、股东代表及其 代表的有表决权的股份数额 3、董事、总工程师杨红文先生宣读会议须知 二、会议议案报告 序号 议案名称 报告人 1 关于更换公司董事的议案 谢金明 现场会议时间：2024年7月30日14:30 现场会议地点：阜阳市清河东路523号金种子研发大楼9楼会议室 主持人：董事长谢金明先生 2024 年第一次临时股 ...